Latest News about NKTR
Recent news which mentions NKTR
Stocks That Hit 52-Week Lows On Tuesday
March 21, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 14, 2023
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 28, 2023
From Benzinga
Dow Dips 350 Points; S&P 500 Down Over 1%
February 24, 2023
From Benzinga
Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 24, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 24, 2023
From Benzinga
Nasdaq Tumbles 2%; Timber Pharmaceuticals Shares Spike Higher
February 24, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
February 24, 2023
From Benzinga
US Stocks Open Lower; Dow Drops 1%
February 24, 2023
From Benzinga
From InvestorPlace
BA Stock Alert: Boeing Halts Deliveries of 787 Dreamliners
February 24, 2023
From InvestorPlace
Why Is Nektar Therapeutics (NKTR) Stock Down 39% Today?
February 24, 2023
From InvestorPlace
Why Nektar Therapeutics Stock Is Plunging Today
February 24, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 24, 2023
From Benzinga
Why Beyond Meat Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
February 24, 2023
From Benzinga
From InvestorPlace
Boeing stock slips after deliveries of 787s halted; Beyond Meat shares rally after plant-food maker’s results
February 24, 2023
From MarketWatch
US Stocks Stare At More Losses In a Lackluster Week: Can Inflation Data Salvage Year's Rally?
February 24, 2023
From Benzinga
BigCommerce, ContextLogic And Other Big Stocks Moving Lower In Friday's Pre-Market Session
February 24, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 30, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 29, 2022
From Benzinga
Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated'
November 21, 2022
From Benzinga
Nasdaq, S&P 500 Futures Pullback At Start Of New Trading Week As Rate Fears Return To Haunt; AMD, Tesla, Biogen, Eli Lilly, JD In Focus
November 14, 2022
From Benzinga
PureTech Health Confirms 'Possible' Merger With Nektar Therapeutics
October 07, 2022
From Benzinga
Nektar Therapeutics's Return On Capital Employed Insights
August 23, 2022
Tickers
NKTR
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.